Transient hepatitis B surface antigenemia after hepatitis B virus vaccine in an HIV-infected patient. 2013

Sarah Barbour, and Laura Bachmann, and Marina Núñez

UI MeSH Term Description Entries
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012698 Serologic Tests Diagnostic procedures involving immunoglobulin reactions. Serodiagnosis,Serologic Test,Serological Tests,Test, Serologic,Tests, Serologic,Serodiagnoses,Serological Test,Test, Serological,Tests, Serological
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D017325 Hepatitis B Vaccines Vaccines or candidate vaccines containing inactivated hepatitis B or some of its component antigens and designed to prevent hepatitis B. Some vaccines may be recombinantly produced. Hepatitis B Vaccine,Vaccine, Hepatitis B,Vaccines, Hepatitis B

Related Publications

Sarah Barbour, and Laura Bachmann, and Marina Núñez
December 1996, Acta paediatrica (Oslo, Norway : 1992),
Sarah Barbour, and Laura Bachmann, and Marina Núñez
April 2003, Transfusion,
Sarah Barbour, and Laura Bachmann, and Marina Núñez
June 2011, NDT plus,
Sarah Barbour, and Laura Bachmann, and Marina Núñez
June 2021, Mayo Clinic proceedings. Innovations, quality & outcomes,
Sarah Barbour, and Laura Bachmann, and Marina Núñez
June 2014, AIDS (London, England),
Sarah Barbour, and Laura Bachmann, and Marina Núñez
June 2000, Pediatrics,
Sarah Barbour, and Laura Bachmann, and Marina Núñez
August 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Sarah Barbour, and Laura Bachmann, and Marina Núñez
July 1983, Infection and immunity,
Sarah Barbour, and Laura Bachmann, and Marina Núñez
November 1989, Archives of pathology & laboratory medicine,
Copied contents to your clipboard!